Literature DB >> 21984419

Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.

Michaela Aichler1, Christopher Seiler, Monica Tost, Jens Siveke, Pawel K Mazur, Patricia Da Silva-Buttkus, Detlef K Bartsch, Peter Langer, Sara Chiblak, Anna Dürr, Heinz Höfler, Günter Klöppel, Karin Müller-Decker, Markus Brielmeier, Irene Esposito.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) and its precursor lesions, pancreatic intraepithelial neoplasia (PanIN), display a ductal phenotype. However, there is evidence in genetically defined mouse models for PDAC harbouring a mutated kras under the control of a pancreas-specific promoter that ductal cancer might arise in the centroacinar-acinar region, possibly through a process of acinar-ductal metaplasia (ADM). In order to further elucidate this model of PDAC development, an extensive expression analysis and molecular characterization of the putative and already established (PanIN) precursor lesions were performed in the Kras(G12D/+) ; Ptf1a-Cre(ex1/+) mouse model and in human tissues, focusing on lineage markers, developmental pathways, cell cycle regulators, apomucins, and stromal activation markers. The results of this study show that areas of ADM are very frequent in the murine and human pancreas and represent regions of increased proliferation of cells with precursor potential. Moreover, atypical flat lesions originating in areas of ADM are the most probable precursors of PDAC in the Kras(G12D/+); Ptf1a-Cre(ex1/+) mice and similar lesions were also found in the pancreas of three patients with a strong family history of PDAC. In conclusion, PDAC development in Kras(G12D/+); Ptf1a-Cre(ex1/+) mice starts from ADM and a similar process might also take place in patients with a strong family history of PDAC.
Copyright © 2012 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21984419     DOI: 10.1002/path.3017

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  52 in total

Review 1.  Familial pancreatic cancer--current knowledge.

Authors:  Detlef K Bartsch; Thomas M Gress; Peter Langer
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-05       Impact factor: 46.802

2.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

Review 3.  Familial pancreatic cancer--status quo.

Authors:  Volker Fendrich; Peter Langer; Detlef K Bartsch
Journal:  Int J Colorectal Dis       Date:  2013-08-16       Impact factor: 2.571

Review 4.  Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.

Authors:  Irene Esposito; Björn Konukiewitz; Anna Melissa Schlitter; Günter Klöppel
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 5.  Notch signaling in pancreatic cancer: oncogene or tumor suppressor?

Authors:  Jacqueline L Avila; Joseph L Kissil
Journal:  Trends Mol Med       Date:  2013-03-29       Impact factor: 11.951

Review 6.  Energy metabolism and proliferation in pancreatic carcinogenesis.

Authors:  Ivonne Regel; Bo Kong; Susanne Raulefs; Mert Erkan; Christoph W Michalski; Mark Hartel; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2012-03-20       Impact factor: 3.445

Review 7.  Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.

Authors:  Peter Storz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-08       Impact factor: 46.802

Review 8.  Early detection and prevention of pancreatic cancer: is it really possible today?

Authors:  Marco Del Chiaro; Ralf Segersvärd; Matthias Lohr; Caroline Verbeke
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 9.  Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.

Authors:  Michael Friberg Bruun Nielsen; Michael Bau Mortensen; Sönke Detlefsen
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 10.  Mechanistic insights into self-reinforcing processes driving abnormal histogenesis during the development of pancreatic cancer.

Authors:  Juan L Iovanna; David L Marks; Martin E Fernandez-Zapico; Raul Urrutia
Journal:  Am J Pathol       Date:  2013-01-31       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.